Dr Regueiro, professor and chair of the Department of Gastroenterology, Hepatology, and Nutrition at the Cleveland Clinic, spoke to the Advances in Inflammatory Disease regional meeting on April 16 about the potential and promise of a new therapeutic agent, S1P modulators.
Dr Ha, from Cedars-Sinai in Los Angeles, reviews her presentation from the Advances in Inflammatory Bowel Disease regional meeting April 16 on how to help young patients with IBD make a smooth transition from pediatric to adult care.
Dr Chiorean, from the Virginia Mason Medical Center in Seattle, discusses his presentation at the Advances in Inflammatory Bowel Diseases 2021 regional meeting on April 16 on how to use Janus kinase inhibitors in managing inflammatory bowel disease.
In this video Dr Melmed, from Cedars-Sinai in Los Angeles, discusses the increased risk of C. difficile among patients with inflammatory bowel disease and the range of therapies available for treating this infection, which he presented at the Advances in Inflammatory Bowel Diseases regional meeting April 16.
Dr Melmed, from Cedars-Sinai in Los Angeles, previews the panel session on positioning therapies in IBD that he will chair at the Advances in Inflammatory Bowel Diseases 2021 regional meeting April 16.
In this video, Dr Long, from the University of North Carolina at Chapel Hill, discusses the use of endoscopic severity and the course of disease to help define disease severity in ulcerative colitis and to choose therapeutic options for patients with moderate to severe ulcerative colitis.
Dr Peery, from the University of North Carolina, discusses a study of the comparative effectiveness and harms of metronidazole-with-fluoroquinolone vs amoxicillin-clavulanate in treatment of diverticulitis among nonhospitalized patients.
Dr Dubinsky, from the Icahn School of Medicine in New York, discusses the findings of the PIANO study confirming that control of inflammatory bowel disease in pregnancy is the key to optimal outcomes.
Dr Dubinsky, from the Icahn School of Medicine at Mount Sinai in New York City, reviews her presentation from the Advances in Inflammatory Bowel Diseases 2021 virtual regional meeting March 6 on how biomarkers can provide greater precision in choosing therapies and dosing regimens for patients with IBD.
Dr Abraham, from Houston Methodist Weill Cornell, discusses how to treat skin, eye, and joint issues often seen in patients with inflammatory bowel disease.